Company
St Lucia, QLD
Every investor coverage indicates participated in a round Australian Institute for Bioengineering and Nanotechnology raised.
Companies Australian Institute for Bioengineering and Nanotechnology acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Australian Institute for Bioengineering and Nanotechnology. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Brandon BioCatalyst has named Peter Beattie its chair as Bill Ferris retires, with Andrew Nash joining the board and Ross King becoming deputy; manager Brandon Capital's newly raised $439 million fund was noted.
Roundup of Australian manufacturing news: Matrak closes a Series A, Queensland Pacific Metals receives an R&D tax refund, ARENA funds a household energy trial, Ampcontrol appoints a transformation chief, plus policy and launch briefs.
Also @AuManufacturing
Vaxxas, a Queensland biotech developing needle-free vaccine patches, has banked a $25 million Series B led by OneVentures, following an earlier $15 million Series A round.
Also Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon BioCatalyst portfolio·labonline.com.au·SmartCompany·labonline.com.au